General and administrative expenses also include legal fees relating to patents and corporate matters; professional fees for accounting, auditing, tax, and consulting services; insurance costs; travel expenses; and facility-related expenses, which include depreciation costs and expenses for rent and maintenance of facilities and other operating costs.

filing / Aug 11, 2026 / receipt

• costs of outside consultants, including their fees and related travel expenses; and • costs associated with license agreements to support the development of our technology.

filing / Aug 11, 2026 / receipt

The increase in personnel expenses of $2.4 million was primarily due to increased headcount in our research and development function.

filing / Aug 11, 2026 / receipt

The decrease of $0.3 million was primarily driven by a decrease of $0.9 million in professional fees primarily related to market research costs and legal fees during the three months ended June 30, 2026, compared to the same period in 2025, partially offset by an increase in personnel expenses of $0.6 million due to increased headcount in our general and administrative functions.

filing / Aug 11, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products.

filing / Aug 11, 2026 / receipt

These increased costs will continue to decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services.

filing / Aug 11, 2026 / receipt

General and administrative expenses also include legal fees relating to patents and corporate matters; professional fees for accounting, auditing, tax, and consulting services; insurance costs; travel expenses; and facility-related expenses, which include depreciation costs and expenses for rent and maintenance of facilities and other operating costs.

filing / May 13, 2026 / receipt

• costs of outside consultants, including their fees and related travel expenses; and • costs associated with license agreements to support the development of our technology.

filing / May 13, 2026 / receipt

The increase in personnel expenses of $3.5 million was primarily due to increased headcount in our research and development function.

filing / May 13, 2026 / receipt

The increase of $1.3 million was primarily driven by an increase in personnel expenses of $0.7 million due to increased headcount in our general and administrative functions.

filing / May 13, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products.

filing / May 13, 2026 / receipt

These increased costs will continue to decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services.

filing / May 13, 2026 / receipt